Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Decreased ALCAM expression and promoter hypermethylation is associated with preeclampsia

Abstract

Preeclampsia (PE) is a major obstetrical complication that results in maternal and fetal morbidity and mortality. Aberrant epigenetic modifications are widely involved in the pathogenesis of PE. Previously, the activated leukocyte cell adhesion molecule (ALCAM) was reported to be required for blastocyst implantation but has not been described in the context of pathological pregnancy. This study explored the expression of ALCAM and its methylation levels in the placentas and peripheral venous blood of patients with PE from a Chinese Han population. The mRNA and protein expression levels of ALCAM were downregulated in the PE placentas compared with the control placentas (P < 0.05). The methylation rate of the ALCAM gene promoter was considerably elevated in the placentas (P = 0.003, odds ratio (OR) = 0.264, 95% confidence interval (95% CI) [0.108–0.647], cases n = 47, controls n = 53) and peripheral blood (P = 0.007, OR = 0.455, 95% CI [0.256–0.806], cases n = 100, controls n = 100) of the PE patients compared with those of the normotensive women, suggesting a negative relationship between ALCAM methylation and gene transcription. Moreover, the transcriptional expression of ALCAM was dramatically increased by demethylating treatment in trophoblastic cells. ALCAM is expected to be involved in the pathogenesis of PE through methylation regulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Mol B, Roberts C, Thangaratinam S, Magee L, de Groot C, Hofmeyr G. Pre-eclampsia. Lancet. 2016;387:999–1011.

    Article  Google Scholar 

  2. Nevalainen J, Skarp S, Savolainen E, Ryynänen M, Järvenpää J. Intrauterine growth restriction and placental gene expression in severe preeclampsia, comparing early-onset and late-onset forms. J Perinat Med. 2017;45:869–77.

    Article  CAS  Google Scholar 

  3. Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ. Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech. 2012;5:9–18.

    Article  CAS  Google Scholar 

  4. Jannie KM, Stipp CS, Weiner JA. ALCAM regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells. PLoS ONE. 2012;7:e39330.

    Article  CAS  Google Scholar 

  5. Devis L, Moiola CP, Masia N, Martinez-Garcia E, Santacana M, Stirbat TV, et al. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer. J Pathol. 2017;241:475–87.

    Article  CAS  Google Scholar 

  6. Haouzi D, Dechaud H, Assou S, Monzo C, de Vos J, Hamamah S. Transcriptome analysis reveals dialogues between human trophectoderm and endometrial cells during the implantation period. Hum Reprod. (Oxford, England). 2011;26:1440–9.

    Article  CAS  Google Scholar 

  7. Lian IA, Toft JH, Olsen GD, Langaas M, Bjorge L, Eide IP, et al. Matrix metalloproteinase 1 in pre-eclampsia and fetal growth restriction: reduced gene expression in decidual tissue and protein expression in extravillous trophoblasts. Placenta. 2010;31:615–20.

    Article  CAS  Google Scholar 

  8. Panagodage S, Yong HE, Da Silva Costa F, Borg AJ, Kalionis B, Brennecke SP, et al. Low-dose acetylsalicylic acid treatment modulates the production of cytokines and improves trophoblast function in an in vitro model of early-onset preeclampsia. Am J Pathol. 2016;186:3217–24.

    Article  CAS  Google Scholar 

  9. Ge J, Wang J, Zhang F, Diao B, Song ZF, Shan LL, et al. Correlation between MTHFR gene methylation and pre-eclampsia, and its clinical significance. Genet Mol Res. 2015;14:8021–8.

    Article  CAS  Google Scholar 

  10. Chu T, Bunce K, Shaw P, Shridhar V, Althouse A, Hubel C, et al. Comprehensive analysis of preeclampsia-associated DNA methylation in the placenta. PLoS ONE. 2014;9:e107318.

    Article  Google Scholar 

  11. Anderson CM, Ralph JL, Wright ML, Linggi B, Ohm JE. DNA methylation as a biomarker for preeclampsia. Biol Res Nurs. 2014;16:409–20.

    Article  CAS  Google Scholar 

  12. Anton L, Brown AG, Bartolomei MS, Elovitz MA. Differential methylation of genes associated with cell adhesion in preeclamptic placentas. PLoS ONE. 2014;9:e100148.

    Article  Google Scholar 

  13. Xuan J, Jing Z, Yuanfang Z, Xiaoju H, Pei L, Guiyin J, et al. Comprehensive analysis of DNA methylation and gene expression of placental tissue in preeclampsia patients. Hypertens Pregnancy. 2016;35:129–38.

    Article  Google Scholar 

  14. Yeung KR, Chiu CL, Pidsley R, Makris A, Hennessy A, Lind JM. DNA methylation profiles in preeclampsia and healthy control placentas. Am J Physiol Heart Circ Physiol. 2016;310:H1295–303.

    Article  Google Scholar 

  15. Piletič K, Kunej T. MicroRNA epigenetic signatures in human disease. Arch Toxicol. 2016;90:2405–19.

    Article  Google Scholar 

  16. Robinson WP, Price EM. The human placental methylome. Cold Spring Harb Perspect Med. 2015;5:a023044.

    Article  Google Scholar 

  17. Ching T, Song MA, Tiirikainen M, Molnar J, Berry M, Towner D, et al. Genome-wide hypermethylation coupled with promoter hypomethylation in the chorioamniotic membranes of early onset pre-eclampsia. Mol Hum Reprod. 2014;20:885–904.

    Article  CAS  Google Scholar 

  18. Rahat B, Najar R, Hamid A, Bagga R, Kaur J. The role of aberrant methylation of trophoblastic stem cell origin in the pathogenesis and diagnosis of placental disorders. Prenat Diagn. 2017;37:133–43.

    Article  CAS  Google Scholar 

  19. Novakovic B, Evain-Brion D, Murthi P, Fournier T, Saffery R. Variable DAXX gene methylation is a common feature of placental trophoblast differentiation, preeclampsia, and response to hypoxia. FASEB J. 2017;31:2380–92.

    Article  CAS  Google Scholar 

  20. Lowe SA, Bowyer L, Lust K, McMahon LP, Morton M, North RA, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol. 2015;55:e1–29.

    Article  Google Scholar 

  21. Grotegut C. Prevention of preeclampsia. J Clin Invest. 2016;126:4396–8.

    Article  Google Scholar 

  22. Jia Y, Li T, Huang X, Xu X, Zhou X, Jia L, et al. Dysregulated DNA methyltransferase 3A upregulates IGFBP5 to suppress trophoblast cell migration and invasion in preeclampsia. Hypertension. 2017;69:356–66.

    Article  CAS  Google Scholar 

  23. Martin E, Ray P, Smeester L, Grace M, Boggess K, Fry R. Epigenetics and preeclampsia: defining functional epimutations in the preeclamptic placenta related to the TGF-β pathway. PLoS ONE. 2015;10:e0141294.

    Article  Google Scholar 

  24. Brew O, Sullivan MH, Woodman A. Comparison of normal and pre-eclamptic placental gene expression: a systematic review with meta-analysis. PLoS ONE. 2016;11:e0161504.

    Article  CAS  Google Scholar 

  25. Fujiwara K, Ohuchida K, Sada M, Horioka K, Ulrich CD 3rd, Shindo K, et al. CD166/ALCAM expression is characteristic of tumorigenicity and invasive and migratory activities of pancreatic cancer cells. PLoS ONE. 2014;9:e107247.

    Article  Google Scholar 

  26. Jeong YJ, Oh HK, Park SH, Bong JG. Prognostic significance of activated leukocyte cell adhesion molecule (ALCAM) in association with promoter methylation of the ALCAM gene in breast cancer. Molecules. 2018;23:131.

    Article  Google Scholar 

  27. Lu XY, Chen D, Gu XY, Ding J, Zhao YJ, Zhao Q, et al. Predicting value of ALCAM as a target gene of microRNA-483-5p in patients with early recurrence in hepatocellular carcinoma. Front Pharm. 2017;8:973.

    Article  Google Scholar 

  28. Smith NR, Davies PS, Levin TG, Gallagher AC, Keene DR, Sengupta SK, et al. Cell adhesion molecule CD166/ALCAM functions within the crypt to orchestrate murine intestinal stem cell homeostasis. Cell Mol Gastroenterol Hepatol. 2017;3:389–409.

    Article  Google Scholar 

  29. Fujiwara H, Tatsumi K, Kosaka K, Sato Y, Higuchi T, Yoshioka S, et al. Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166). J Clin Endocrinol Metab. 2003;88:3437–43.

    Article  CAS  Google Scholar 

  30. Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, AlTalabani AA, et al. Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Stem cell reviews. 2013;9:16–31.

    Article  CAS  Google Scholar 

  31. Rezaei M, Eskandari F, Mohammadpour-Gharehbagh A, Harati-Sadegh M, Teimoori B, Salimi S. Hypomethylation of the miRNA-34a gene promoter is associated with Severe Preeclampsia. Clin Exp Hypertens. 2018;41:1–5.

    Article  Google Scholar 

  32. Blair JD, Yuen RK, Lim BK, McFadden DE, von Dadelszen P, Robinson WP. Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia. Molecular human reproduction. 2013;19:697–708.

    Article  CAS  Google Scholar 

  33. Orhant L, Rondeau S, Vasson A, Anselem O, Goffinet F, Allach El Khattabi L, et al. Droplet digital PCR, a new approach to analyze fetal DNA from maternal blood: application to the determination of fetal RHD genotype. Ann Biol Clin. 2016;74:269–77.

    Google Scholar 

  34. Shea J, Diamandis E, Hoffman B, Lo Y, Canick J, van den Boom D. A new era in prenatal diagnosis: the use of cell-free fetal DNA in maternal circulation for detection of chromosomal aneuploidies. Clin Chem. 2013;59:1151–9.

    Article  CAS  Google Scholar 

Download references

Funding

This research was supported by funding from the National Science Foundation of the P.R. China (No. 81600211); the Science Foundation of Shandong Province (ZR2016HM28 and ZR2014HP017); and by the Application and Basic Research Project of Qingdao (18-2-2-27-jch).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization, LZ and SL; Data curation, LZ and SL; Formal analysis, JL; Funding acquisition, LZ and SL; Investigation, ZY and WS; Methodology, QT and LZ; Project administration, LZ and SL; Resources, SL; Software, LW and YP; Supervision, ZY, WS, YG, QT and JL; Validation, LW, YP and YG; Writing—original draft, LW and YP; Writing—review and editing, LZ and SL.

Corresponding authors

Correspondence to Lu Zhang or Shi-guo Liu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wei, Ll., Pan, Ys., Tang, Q. et al. Decreased ALCAM expression and promoter hypermethylation is associated with preeclampsia. Hypertens Res 43, 13–22 (2020). https://doi.org/10.1038/s41440-019-0337-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-019-0337-0

Keywords

Search

Quick links